drugset

drugset / Trial / NCT00913237

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets

NCT00913237 ↗

Phase 1 Completed 36 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Desipramine Hydrochloride 50 mg tablets.

Timeline

Start: 1987-07
Primary completion: 1987-08
Completion: 1987-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Desipramine	Small molecule	50 mg	—

Indications